Assessment of haemostasis

Vox Sanguinis, Supplement

Volumn 87, Issue 1, 2004, Pages

  Greaves, M ^a  

^a Dept of Medicine and Therapeutics ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BATROXOBIN; BLOOD CLOTTING FACTOR 12; FIBRIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTAMINE;

ACUTE PHASE RESPONSE; BLEEDING; BLEEDING TIME; BLOOD; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 12 DEFICIENCY; BLOOD CLOTTING PARAMETERS; BLOOD CLOTTING TIME; CONFERENCE PAPER; CONGENITAL BLOOD CLOTTING DISORDER; DEVICE; DIAGNOSTIC ERROR; DRUG CONTAMINATION; EPISTAXIS; FIBRINOLYSIS; HEMOSTASIS; HUMAN; LABORATORY TEST; LUPUS ERYTHEMATOSUS; MENORRHAGIA; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; PROTAMINE CORRECTION; PROTHROMBIN TIME; REPTILASE TIME; SCREENING TEST; SURGICAL TECHNIQUE; THROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; HEMORRHAGE; HEMOSTASIS; HEMOSTASIS, SURGICAL; HUMANS;

EID: 4344624206     PISSN: 17416892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Chee Y-L, Greaves M: The role of coagulation testing in predicting bleeding risk. Haematol J 2003; 4:373-378
2. Greaves M, Preston FE: Approach to the bleeding patient; in Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN (eds): Hemostasis and Thrombosis, Basic Principles and Clinical Practice, 4th edn. Lippincott, Williams & Wilkins: Philadelphia, 2000:783-793
3. Barber A, Green D, Galuzzo T, Ts'ao C-H: The bleeding time as a preoperative screening test. Am J Med 1985; 78:761-764
4. Burk CD, Miller L, Handler SD, Cohen AR: Preoperative history and coagulation screening in children undergoing tonsillectomy. Pediat 1992; 89:691-695
5. Eisenberg JM, Clarke JR, Sussman SS: Prothrombin and partial thromboplastin times as preoperative screening tests. Arch Surg 1982; 117:48-51
6. Hathaway WE, Assmus SL, Montgomery RR, Dubansky AS: Activated partial thromboplastin time and minor coagulopathies. Am J Clin Pathol 1979; 71:22-25
7. Howells RC, Wax MK, Ramadan HH: Value of preoperative prothrombin/partial thromboplastin time as a predictor of postoperative hemorrhage in pediatric patients undergoing tonsillectomy. Otolaryngology-Head Neck Surg 1997; 117:628-632
8. Kaplan EB, Scheiner LB, Boeckmann AJ, Roizen MF, Beal SL, Cohen SN, Nicoll CD: The usefulness of preoperative laboratory screening. JAMA 1985; 253:3576-3581
9. Turnbull JM, Buck C: The value of preoperative screening investigations in otherwise healthy individuals. Arch Intern Med 1987; 147:1101-1105
10. Turi DC, Peerschke EI: Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies. Am J Clin Pathol 1986; 85:43-49
11. Lawrie AS, Kitchen S, Purdy G, Mackie IJ, Preston FE, Machin SJ: Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies. Clin Lab Haematol 1998; 20:179-186
12. Greaves M: Limitations of the laboratory monitoring of heparin therapy. Thrombos Haemostas 2002; 87:163-164
13. Halbmayer WM, Haushofer A, Schon R, Mannhalter C, Strohmer E, Baumgarten K, Fischer M: The prevalence of moderate and severe FXII (Hageman factor) deficiency among the normal population: evaluation of the incidence FXII deficiency among 300 healthy blood donors. Thromb Haemost 1994; 71:68-72
14. Lind SE: The bleeding time does not predict surgical bleeding. Blood 1991; 77:2547-2552
15. Salooja N, Perry DJ: Thromboelastography. Blood Coagul Fibrinolysis 2001; 12:327-337
16. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA: The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96:51-57
17. Kovacs IB: Preoperative hemostatic activity and excessive bleeding after cardiopulmonary bypass. Ann Thorac Surg 1991; 52:250-257
18. Ti LK, Cheong KF, Chen FG: Prediction of excessive bleeding after coronary artery bypass graft surgery: the influence of timing and heparinase on thromboelastography. J Cardiothorac Vase Anesth 2002; 16:545-550
19. McNicol PL, Liu G, Harley ID, McCall PR, Przybylowski GM, Bowkett J, Angus PW, Hardy KJ, Jones RM: Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thromboelastography. Anaesth Intensive Care 1994; 22:659-665
20. Harrison P, Robinson M, Liesner R, Khair K, Cohen H, Mackie I, Machin S: The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol 2002; 24:225-232
21. Fattorutto M, Pradier O, Schmartz D, Ickx B, Barvais L: Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? Br J Anaesth 2003; 90:692-693
22. Forestier F, Coiffic A, Mouton C, Ekouevi D, Chene G, Janvier G: Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant? Br J Anaesth 2002; 89:715-721
23. Wahba A, Sander S, Birnbaum DE: Are in-vitro platelet function tests useful in predicting blood loss following open heart surgery? Thorac Cardiovasc Surg 1998; 46:228-231